Health Canada inspection
Sumitomo Dainippon Pharma Co., Ltd.: Health Canada inspection of Aug 31, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Sumitomo Dainippon Pharma Co., Ltd. |
|---|---|
| City | Oita |
| Province | Ôita |
| Country | Japan |
| Program | GMP |
| Start date | Aug 22, 2022 |
| End date | Aug 31, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.